REVVITY ESPANA SL secures contract for Laboratory Reagents- Acquisition of material used in the detection of endocrinomethabolic diseases and other diseases included in the neonatal screening program: Determination of TSH, T4, IRT, Biotinidase, 17 A-OH- Progesterone, amino acids and acylcarnitinas

Spain, April 24 -- Spain based REVVITY ESPANA SL has secured contract from Organo Administrativo de Recursos Contractuales for Laboratory Reagents- Acquisition of material used in the detection of endocrinomethabolic diseases and other diseases included in the neonatal screening program: Determination of TSH, T4, IRT, Biotinidase, 17 A-OH- Progesterone, amino acids and acylcarnitinas. The value of the contract is worth 48146164 EUR.

Published by HT Digital Content Services with permission from Pivotal Sources....